Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer

Nature Genetics

Volumn 40, Issue 12, 2008, Pages 1426-1435

  Houlston, Richard S ^a   Webb, Emily ^a   Broderick, Peter ^a   Pittman, Alan M ^a   Di Bernardo, Maria Chiara ^a   Lubbe, Steven ^a   Chandler, Ian ^a   Vijayakrishnan, Jayaram ^a   Sullivan, Kate ^a   Penegar, Steven ^a   Carvajal Carmona, Luis ^b   Howarth, Kimberley ^b   Jaeger, Emma ^b   Spain, Sarah L ^b   Walther, Axel ^b   Barclay, Ella ^b   Martin, Lynn ^b   Gorman, Maggie ^b   Domingo, Enric ^b   Teixeira, Ana S ^b   Kerr, David ^c   Cazier, Jean Baptiste ^b   Niittymäki, Iina ^d   Tuupanen, Sari ^d   Karhu, Auli ^d   Aaltonen, Lauri A ^d   Tomlinson, Ian P M ^b   Farrington, Susan M ^e   Tenesa, Albert ^e   Prendergast, James G D ^e   Barnetson, Rebecca A ^e   Cetnarskyj, Roseanne ^f   Porteous, Mary E ^f   Pharoah, Paul D P ^g   Koessler, Thibaud ^g   Hampe, Jochen ^h   Buch, Stephan ^h   Schafmayer, Clemens ^h   Tepel, Jurgen ^h   Schreiber, Stefan ^h   Völzke, Henry ⁱ   Chang Claude, Jenny ^j   Hoffmeister, Michael ^j   Brenner, Hermann ^j   Zanke, Brent W ^k   Montpetit, Alexandre ^l   Hudson, Thomas J ^l,m,n   Gallinger, Steven ^m,n   Campbell, Harry ^e   Dunlop, Malcolm G ^e   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^l MCGILL UNIVERSITY   (Canada)

^m CANCER CARE ONTARIO   (Canada)

ⁿ ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; COLORECTAL CANCER; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED;

EID: 56749176944     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.262     Document Type: Article

References (44)

1. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78-85 (2000).
2. Aaltonen, L., Johns, L., Jarvinen, H., Mecklin, J.P. & Houlston, R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin. Cancer Res. 13, 356-361 (2007).
3. Tomlinson, I. et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39, 984-988 (2007).
4. Zanke, B.W. et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 39, 989-994 (2007).
5. Tomlinson, I.P. et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet. 40, 623-630 (2008).
6. Tenesa, A. et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet. 40, 631-637 (2008).
7. Jaeger, E. et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat. Genet. 40, 26-28 (2008).
8. Broderick, P. et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet. 39, 1315-1317 (2007).
9. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649 (2007).
10. Kim, J.S. et al. Oncogenic β-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res. 62, 2744-2748 (2002).
11. He, X.C. et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat. Genet. 36, 1117-1121 (2004).
12. Howe, J.R. et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28, 184-187 (2001).
13. Zhou, X.P. et al. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am. J. Hum. Genet. 69, 704-711 (2001).
14. Peck, J.W., Oberst, M., Bouker, K.B., Bowden, E. & Burbelo, P.D. The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization. J. Biol. Chem. 277, 43924-43932 (2002).
15. Bellovin, D.I. et al. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25, 6959-6967 (2006).
16. Chang, Y.W., Marlin, J.W., Chance, T.W. & Jakobi, R. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility. Cancer Res. 66, 11700-11708 (2006).
17. Behrens, J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem. Soc. Trans. 33, 672-675 (2005).
18. Wheeler, J.M. et al. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48, 367-371 (2001).
19. Guilford, P. et al. E-cadherin germline mutations in familial gastric cancer. Nature 392, 402-405 (1998).
20. Richards, F.M. et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum. Mol. Genet. 8, 607-610 (1999).
21. Salahshor, S. et al. A germline E-cadherin mutation in a family with gastric and colon cancer. Int. J. Mol. Med. 8, 439-443 (2001).
22. Li, L.C. et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 60, 873-876 (2000).
23. Stranger, B.E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-853 (2007).
24. Stranger, B.E. et al. Genome-wide associations of gene expression variation in humans. PLoS Genet. 1, e78 (2005).
25. Ghoussaini, M. et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J. Natl. Cancer Inst. 100, 962-966 (2008).
26. Haiman, C.A. et al. A common genetic risk factor for colorectal and prostate cancer. Nat. Genet. 39, 954-956 (2007).
27. Penegar, S. et al. National study of colorectal cancer genetics. Br. J. Cancer 97, 1305-1309 (2007).
28. Eisen, T., Matakidou, A., Consortium, G. & Houlston, R. Identification of low penetrance alleles for lung cancer: The GEnetic Lung CAncer Predisposition Study (GELCAPS). BMC Cancer 8, 244 (2008).
29. Smith, B.H. et al. Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability. BMC Med. Genet. 7, 74 (2006).
30. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41 (2006).
31. World Health Organization. International Classification of Diseases. 1975 Revision (World Health Organization, Geneva, 1977).
32. Zhou, X.P. et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 21, 101-107 (1998).
33. Boland, C.R. et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257 (1998).
34. Petitti, D. Meta-analysis Decision Analysis and Cost-Effectiveness Analysis (Oxford, New York, Oxford, 1994).
35. Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002).
36. Houlston, R.S. & Ford, D. Genetics of coeliac disease. QJM 89, 737-743 (1996).
37. Cox, A. et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 39, 352-358 (2007).
38. Johns, L.E. & Houlston, R.S. A systematic review and meta-analysis of familial colorectal cancer risk. Am. J. Gastroenterol. 96, 2992-3003 (2001).
39. Di Bernardo, M.C. et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 40, 1204-1210 (2008).
40. Skol, A.D., Scott, L.J., Abecasis, G.R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38, 209-213 (2006).
41. Antoniou, A.C. & Easton, D.F. Polygenic inheritance of breast cancer: Implications for design of association studies. Genet. Epidemiol. 25, 190-202 (2003).
42. Garcia-Closas, M. & Lubin, J.H. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am. J. Epidemiol. 149, 689-692 (1999).
43. Lubin, J.H. & Gail, M.H. On power and sample size for studying features of the relative odds of disease. Am. J. Epidemiol. 131, 552-566 (1990).
44. Cuzick, J. A Wilcoxon-type test for trend. Stat. Med. 4, 87-90 (1985).